* Predictive Oncology Inc POAI.OQ reported a quarterly
adjusted
loss of 13 cents per share for the quarter ended in December.
The mean expectation of two analysts for the quarter was for a
loss of 2 cents per share.
* Revenue rose 62% to $476.00 thousand from a year ago;
analysts
expected $2.50 million.
* Predictive Oncology Inc's reported EPS for the quarter was
a
loss of 13 cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Predictive Oncology Inc shares had risen by 7.2% this
quarter.
* The company reported a quarterly loss of $14.22 million.
* Wall Street's median 12-month price target for Predictive
Oncology Inc is $5.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated March 31 at 11:17 p.m. All
figures in US dollars unless otherwise stated